ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 18/05/2018

Expire date: 02/07/2018

External Reference: 2018-124554

TED Reference: 2018/S 096-219063

Contract notice

Cached Version

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

The Health Research Board
N/A
67-72 Grattan House
Dublin 2
Lower Mount St
IE
Contact person: Dara Murphy
Telephone: +353 12345215
E-mail: dmurphy@hrb.ie
NUTS code:  IE -  IRELAND
Internet address(es):
Main address: www.hrb.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/261

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=129415&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
electronically via:  http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=129415&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Survey to determine the prevalence of the use of illicit drugs, alcohol, prescription drugs and gambling in the general population
Reference number:  HRB 2018 - Gen Pop Survey
II.1.2)

Main CPV code

79311200  -  Survey conduction services
II.1.3)

Type of contract

Services
II.1.4)

Short description

General Population Survey 2018/19
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
II.1.5)

Estimated total value

Value excluding VAT: 575000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

79311000  -  Survey services
79311100  -  Survey design services
II.2.3)

Place of performance

NUTS code:  IE -  IRELAND
II.2.4)

Description of the procurement

The Health Research Board (HRB) is the lead agency in Ireland supporting and funding health research. We provide funding, maintain health information systems and conduct research linked to national health priorities. Our aim is to improve people's health, build health research capacity and make a significant contribution to Ireland's knowledge economy. Our latest Corporate Strategy clearly outlines how we hope to achieve this working in partnership with other organizations.
General Population Survey 2018/19
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).1 Previous surveys were conducted simultaneously in Ireland and Northern Ireland (on behalf of the Public Health Information and Research Branch (PHIRB), within the Department of Health, Social Services and Public Safety). The 2018/19 survey will be conducted in Ireland only.
1. Survey brief
The Health Research Board will commission a fifth survey, to be completed between September 2018 and April 2019. The survey will require a nationally representative proability sample of the persons aged 15 years and over and resident in households in Ireland. The sample size will be in the order of 8,302. The survey will use a pre-prepared questionnaire and interviews will be conducted face-to-face in respondents’ homes using CAPI
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 575000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Start: 10/07/2018  /  End: 09/07/2019
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  25/06/2018
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Duration in months : 12  (from the date stated for receipt of tender)
IV.2.7)

Conditions for opening of tenders

Date:  25/06/2018
Local time:  12:00

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.4)

Procedures for review

VI.4.1)

Review body

High Court
Chief Registrar, The Four Courts
Dublin
7
IE
Telephone: +353 18886000
E-mail: highcourtcentraloffice@courts.ie